Post-COVID Interstitial Lung Disease and Other Lung Sequelae


Mark Barash, DOa,∗ and Vijaya Ramalingam, MD, FCCPa,b Clin Chest Med. 2023 Jun; 44(2): 263–277. Published online 2023 Mar 3. doi: 10.1016/j.ccm.2022.11.019 PMCID: PMC9983785 PMID: 37085219 Author information Copyright and License information PMC Disclaimer As the world emerges from the COVID-19 pandemic, clinicians and researchers across the world are trying to understand the sequelae in patients recovered from COVID-19 infection. In this article, the […]

Post-COVID Interstitial Lung Disease—The Tip of the Iceberg


Namrata Kewalramani, MD,a,b,∗ Kerri-Marie Heenan, MB Bch, BAO,c Denise McKeegan, MB Bch, BAO, MSc,c and Nazia Chaudhuri, MD, PhDd Immunol Allergy Clin North Am. 2023 May; 43(2): 389–410. Published online 2023 Mar3. doi: 10.1016/j.iac.2023.01.004 PMCID: PMC9982726PMID: 37055095 The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. […]

Post-COVID Interstitial Lung Disease: What you Need to Know


Apr 28, 2023 Pulmonary Fibrosis Foundation After being hospitalized for three months with COVID-19 and double pneumonia in 2020, Houston police officer Hito Bazan awoke one morning to discover that he couldn’t talk, eat, walk, or most importantly, breathe. Bazan was diagnosed with interstitial lung disease (ILD) known as pulmonary fibrosis (PF). Three years into […]

Lung Damage & Shortness of Breath After the COVID-19 Vaccine


September 18, 2023 The COVID Long-haul Foundation: Opinion Shortness of breath is a side effect of the COVID-19 vaccine that has been found in vaccinated individuals. It can be caused by a few different things, including: Myocarditis and Pericarditis After the COVID-19 Vaccine Myocarditis and pericarditis are two types of heart inflammation that can occur […]

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)


Jim M Wild1, Joanna C Porter2,3,4, Philip L Molyneaux5,6, Peter M George5,6, http://orcid.org/0000-0002-1340-2688Iain Stewart5, Richard James Allen7, Raminder Aul8, http://orcid.org/0000-0001-5258-793XJohn Kenneth Baillie9, Shaney L Barratt10, Paul Beirne11, Stephen M Bianchi12, John F Blaikley13,14, Jonathan Brooke15,16,17, http://orcid.org/0000-0003-3325-6996Nazia Chaudhuri14,18, Guilhem Collier1, http://orcid.org/0000-0002-7695-325XEmma K Denneny2,3,4, Annemarie Docherty19, http://orcid.org/0000-0002-8250-6464Laura Fabbri5, Michael A Gibbons20,21, Fergus V Gleeson22, Bibek Gooptu23,24, Ian P Hall16,17, Neil A Hanley14,25, Melissa Heightman3, Toby E Hillman3, http://orcid.org/0000-0002-9837-2763Simon R Johnson16,17, Mark G Jones26,27, http://orcid.org/0000-0002-0796-5724Fasihul Khan16,17, Rod Lawson12, Puja Mehta2,28, Jane A Mitchell5, http://orcid.org/0000-0002-9957-0681Manuela Platé2,29, Krisnah Poinasamy30, Jennifer K Quint5, Pilar […]

What Is Interstitial Lung Disease?


By Lana Barhum  November 16, 2022  Medically reviewed by Susan Russell, MD Interstitial lung disease (ILD) includes more than 200 conditions that cause inflammation and scarring of lung tissue.1 The damage done by interstitial lung disease makes it harder for oxygen to enter the bloodstream from the air sacs of the lungs. The prevalence of ILD in the US is […]

Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination


Alison M DeDent, Erica Farrand Correspondence to Dr Alison M DeDent, 513 Parnassus Ave, HSE 1314, Box 0111, University of California San Francisco, San Francisco, California CA 94143, USA; alison.dedent@ucsf.edu The COVID-19 Vaccine: A Historic Achievement with a Rare Adverse Event The first vaccine against SARS-CoV-2 (COVID-19) was given emergency use listing by the World Health Organization (WHO) […]

COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy


J Clin Med. 2023 Aug; 12(15): 4940. Published online 2023 Jul 27. doi: 10.3390/jcm12154940 PMCID: PMC10419957 PMID: 37568341 Authors: Toru Arai, Conceptualization, Resources, Writing – original draft, Writing – review & editing, Funding acquisition,1,* Yu Kurahara, Resources, Writing – review & editing, Supervision,1,2 Mitsuhiro Moda, Resources, Writing – review & editing,3 Takehiko Kobayashi, Resources, Writing – review & editing,1 Yoshinobu Matsuda, Resources, Writing – review & editing,1,3 Tomoko Kagawa, Resources, Writing – review & editing,1,3 Reiko Sugawara, Resources, Writing – review & editing,3 Kazunari Tsuyuguchi, Writing […]

Post-COVID Interstitial Lung Disease: What you Need to Know


Pulmonary Fibrosis Foundation, Apr 28, 2023 After being hospitalized for three months with COVID-19 and double pneumonia in 2020, Houston police officer Hito Bazan awoke one morning to discover that he couldn’t talk, eat, walk, or most importantly, breathe. Bazan was diagnosed with interstitial lung disease (ILD) known as pulmonary fibrosis (PF). Three years into […]

Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties


Athol U. Wells, Anand Devaraj, Sujal R. Desai Jan 26 2021https://doi.org/10.1148/radiol.2021204482 Coronavirus disease 2019 (COVID-19) has now caused more than a million deaths worldwide. These deaths are often due to severe pulmonary involvement. In fatal cases, features of diffuse alveolar damage are a frequent finding. Many survivors with severe infection have long-term residual abnormalities on their thoracic […]